Clorox (NYSE: CLX) shares were trading more than 5% higher after-hours following the company’s reported Q1 results, with EPS coming in at $1.21, beating the consensus estimate of $1.03. Quarterly revenue declined 6% to $1.8 billion, compared to the consensus estimate of $1.7 billion.
According to Linda Rendle, the CEO of Clorox, the company’s Q1 performance put it on track to meet its 2022 outlook, despite the volatile environment and expected continuous cost pressures.
The company confirmed its full 2022-year outlook, expecting a net sales decline of 2% - 6% and an Adjusted EPS of $5.40-$5.70.
精彩评论